Corius Tissue Regeneration Sales SpecialistSelling Hyalomatrix (HYAFF matrix for tissue deficits with exposed bone/tendon) and Plurogel Burn and Wound Gel within areas of trauma, plastics, burn, wound care, general, and orthopedics. Attending all OR surgeon Hyalomatrix application/removals and all patient follow up apts. Completing multiple trials within inpatient and outpatient settings via OR, burn units, and wound clinics.

Selling Total Contact Cast into wound clinics for DFU’s. Responsible for all MD casting training and demos. Selling line of Cutimed Sorbact (silver replacement), chronic wound/postop dressings, Epiona (collagen), Sorbion (super-absorber), and JOBST/FARROW compression (VLU therapy) into hospital systems (both inpatient and outpatient), physician offices, and wound clinics. Key Achievements: Ranking 2nd YTD nationally in growth of 35 representatives upon departure in March of 2018 Achieving $42,000 growth of Epiona sales by March 2018. (748% growth YOY)  Selected 1 of 5 for company funded CWCA training and certification Ranked 11th nationally in 2017, and won Region of the year

INCONTROL MEDICAL – LA, MS 5/12 – CURRENTWomen’s Health Specialist – Medical Device SalesSelling InTone device to OB-GYN’s, urologists, and urogynecologists. InTone is FDA approved for the treatment of female stress, urge, and mixed urinary incontinence. The responsibilities of the position include selling the devices, setting up patients on devices and instructing them on usage, in-servicing doctors and staff on InTone setup, electro-stimulation, program, and software download/usage for biofeedback.

INVENTIV HEALTH – LA, MS, TX, FL 4/08 – 5/12Sales Specialist/ Pharmaceutical Sales SpecialistSuccessfully promoted and organized all aspects of sales for Bayer Healthcare and Spectrum Pharmaceuticals contracts. Sold Bayer diabetic monitors, Contour and Breeze2. Promoted Bayer women’s device/OC YAZ, Beyaz, Natazia, and Safyral to primary care and OB/GYN. On Spectrum contract, sold Fusilev (levoleucovorin) injection in oncology/hematology market. Called on key decision makers in hospitals, clinics, and offices to discuss purchasing trends and decisions.Key Achievements: Increased sales in territory by 25% in 6 months with Fusilev levoleucovorin injection 160% of goal in 2012 of Fusilev sales Ranked 5th of 180 sales representatives in nation in ’10-‘11 launch for Bayer Safyral oral contraceptive sales  Ranked 9th of 180 sales representatives across nation in ’10-‘11 launch Bayer Natazia sales  Ranked in top 10 representatives in country for Bayer Contour and Breeze2 sales per quarter of 60 reps Consistently ranked in the top 15% each quarter with Bayer Diabetes Division sales